Abstract
Drug prior authorization (PA) imposes significant bureaucratic and economic burden on healthcare providers and payers. A novel automated PA system developed by Meuhedet, a large health maintenance organization in Israel, may improve these drawbacks.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have